Plasma osteoprotegerin level on admission is associated with no-reflow phenomenon after primary angioplasty and subsequent left ventricular remodeling in patients with acute ST-segment elevation myocardial infarction

2012 ◽  
Vol 221 (1) ◽  
pp. 254-259 ◽  
Author(s):  
Ayhan Erkol ◽  
Vecih Oduncu ◽  
Selçuk Pala ◽  
Filiz Kızılırmak ◽  
Alev Kılıcgedik ◽  
...  
2020 ◽  
Author(s):  
Jonathan L Ciofani ◽  
Usaid K Allahwala ◽  
Roberto Scarsini ◽  
Avedis Ekmejian ◽  
Adrian P Banning ◽  
...  

Improvements in systems, technology and pharmacotherapy have significantly changed the prognosis over recent decades in patients presenting with ST-segment elevation myocardial infarction. These clinical achievements have, however, begun to plateau and it is becoming increasingly necessary to consider novel strategies to further improve outcomes. Approximately a third of patients treated by primary percutaneous coronary intervention for ST-segment elevation myocardial infarction will suffer from coronary no-reflow (NR), a condition characterized by poor myocardial perfusion despite patent epicardial arteries. The presence of NR impacts significantly on clinical outcomes including left ventricular dysfunction, heart failure and death, yet conventional management algorithms neither assess the risk of NR nor treat NR. This review will provide a contemporary overview on the pathogenesis, diagnosis and treatment of NR.


2013 ◽  
Vol 15 (2) ◽  
pp. 38-43 ◽  
Author(s):  
Danijela Djordjevic-Radojkovic ◽  
Goran Koracevic ◽  
Dragana Stanojevic ◽  
Miodrag Damjanovic ◽  
Svetlana Apostolovic ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document